(Bloomberg) -- Canadian investment firm Onex Corp. is evaluating options including a potential sale of UK health-care staffing business Acacium Group, according to people familiar with the matter. Most Read from Bloomberg Charlie Munger, Who Helped Buffett Build Berkshire, Dies at 99 Saudi Arabia Offers Iran Investment to Limit Israel-Hamas War Bill Ackman Bets Fed Will Cut Interest Rates as Soon as First Quarter Musk’s Cybertruck Is Already a Production Nightmare for Tesla Okta Says Hackers Stole Data for All Customer Support Users The Toronto-based company is working with advisers at Bank of America Corp. to help identify potential suitors for the business, the people said, asking not to be identified as the information is private. London-based Acacium could be valued at about $1.5 billion or more in a sale and is likely to draw interest mostly from buyout firms, the people said. Deliberations are in the early stages and no final decisions have been made, the people said. Onex didn’t respond to requests for comment. A spokesperson for Bank of America declined to comment. Demand for staffing in health care has increased, especially after the coronavirus pandemic, prompting investors to seek exposure to the industry. Acacium provides doctors, nurses and technicians, as well as services, to hospitals and other health agencies. Onex acquired the business in 2020 from another private equity firm, Towerbrook Capital Partners, for an undisclosed amount. Onex this year paused fundraising for its flagship vehicle as rising interest rates and fears of a recession curbed investors’ risk appetite. Raising money for large private equity funds is the “most difficult the industry has ever seen,” Chief Executive Officer Bobby Le Blanc said in September. Most Read from Bloomberg Businessweek Deepfake Pornography Victims Learn There Are No Laws to Fight It Chinese Car Companies Cracked North America by Going to Mexico Scientists and Farmers Race to Save the World’s Banana Supply MBA Alternative Augment Clinches $3.7 Million in New Funding A $30 Billion Meltdown in Clean Energy Puts Biden’s Climate Goals at Risk ©2023 Bloomberg L.P.
Onex Weighs Sale of UK Health-Care Staffing Firm Acacium
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...